# Galectin Therapeutics Inc: Form 8-K, filed Dec 11, 2023

- Company: [Galectin Therapeutics Inc](/companies/galt.md) (CIK 1133416)
- Form: 8-K
- Filed: 2023-12-11
- Accepted by EDGAR: Dec 11, 2023, 21:15 ET
- Period: 2023-12-07
- Accession: 0001140361-23-057155
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1133416/000114036123057155/ef20016443_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1133416/000114036123057155/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1133416/000114036123057155/ef20016443_8k.htm

Filed Dec 11, 2023.
Source: SEC EDGAR, the filing index for accession 0001140361-23-057155. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.